Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

By Crosignani P.G.   Luciano A.   Ray A.   Bergqvist A.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 248-256

Oxford University Press

Access to resources Recommend Favorite

Endometriosis: Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study

By Crosignani Pier Giorgio  

Human Reproduction, Vol. 11, Iss. 12, 1996-12 ,pp. : 2732-2735

Oxford University Press

Access to resources Recommend Favorite

Pituitary apoplexy after leuprolide

By Davis Anu   Goel Shefali   Picolos Michalis   Wang Min   Lavis Victor  

Pituitary, Vol. 9, Iss. 3, 2006-09 ,pp. : 263-265

Springer Publishing Company

Access to resources Recommend Favorite

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)

By Safdarian Leili   Mohammadi Farnoosh Soltani   Alleyassin Ashraf   Aghahosseini Marzieh   Meysamie Alipasha   Rahimi Eiman  

Human Reproduction, Vol. 22, Iss. 9, 2007-09 ,pp. : 2449-2454

Oxford University Press

Access to resources Recommend Favorite

Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer

By Guerra Yannis   Lacuesta Evelyn   Marquez Francisco   Raksin P.   Utset Manuel   Fogelfeld Leon  

Pituitary, Vol. 13, Iss. 1, 2010-03 ,pp. : 54-59

Springer Publishing Company

Access to resources Recommend Favorite